Medicenna Therapeutics Corp. (MDNAF) stock
MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Medicenna Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
No free cash flow figures for Medicenna Therapeutics
Medicenna Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?